Bio-Techne Corp (TECH) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Bio-techne Corp.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:01.077 -- 00:00:06.362 Good morning, and welcome to the Biotechni earnings conference call for the second 00:00:06.362 -- 00:00:09.603 quarter of fiscal year 2026. 00:00:09.825 -- 00:00:14.729 At this time, all participants have been placed in listen-only mode, and the call will 00:00:14.729 -- 00:00:19.374 be open for questions following management's prepared remarks. 00:00:19.374 -- 00:00:25.659 During our Q&A session, please limit yourself to one question and one follow-up. 00:00:25.659 -- 00:00:30.809 I would now like to turn the call over to David Clare, Biotechni's Vice President, 00:00:30.809 -- 00:00:33.309 Investor Relations. 00:00:35.213 -- 00:00:37.675 Good morning and thank you for joining us. 00:00:37.675 -- 00:00:42.239 On the call with me this morning are Kim Kelderman, President and Chief Executive Officer, 00:00:42.239 -- 00:00:46.082 and Jim Hippel, Chief Financial Officer of Biotechni. 00:00:46.082 -- 00:00:50.466 Before we begin, let me briefly cover our safe harbor statement. 00:00:50.466 -- 00:00:54.210 Some of the comments made during this conference call may be considered forward-looking 00:00:54.210 -- 00:00:59.650 statements, including beliefs and expectations about the company's future results. 00:00:59.650 -- 00:01:03.875 The company's 10-K for fiscal year 2025 identifies 00:01:03.875 -- 00:01:08.621 certain factors that could cause the company's actual results to differ materially from 00:01:08.621 -- 00:01:12.847 those projected in the forward-looking statements made during this call. 00:01:12.847 -- 00:01:17.693 The company does not undertake to update any forward-looking statements because of any 00:01:17.693 -- 00:01:21.017 new information or future events or developments. 00:01:21.017 -- 00:01:26.063 The 10-K, as well as...